We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drops Biennial Inspection Requirement for Biologics
FDA Drops Biennial Inspection Requirement for Biologics
The FDA issued a direct final rule removing the biennial inspection requirement for biologics production facilities and adopting a more flexible, risk-based approach to how often the agency will conduct inspections.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor